These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Ex vivo stem cell gene therapy of the skin : Ready for clinical use?]. Koller U Hautarzt; 2020 Feb; 71(2):85-90. PubMed ID: 31965203 [TBL] [Abstract][Full Text] [Related]
24. [Expediting the study on the role of stem cells in wound treatment]. Hu DH Zhonghua Shao Shang Za Zhi; 2010 Aug; 26(4):247-50. PubMed ID: 21029678 [TBL] [Abstract][Full Text] [Related]
25. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. van de Ven C; Collins D; Bradley MB; Morris E; Cairo MS Exp Hematol; 2007 Dec; 35(12):1753-65. PubMed ID: 17949892 [TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stromal cells: properties and role in management of cutaneous diseases. Kim KH; Blasco-Morente G; Cuende N; Arias-Santiago S J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):414-423. PubMed ID: 27549663 [TBL] [Abstract][Full Text] [Related]
27. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Conget P; Rodriguez F; Kramer S; Allers C; Simon V; Palisson F; Gonzalez S; Yubero MJ Cytotherapy; 2010 May; 12(3):429-31. PubMed ID: 20230217 [TBL] [Abstract][Full Text] [Related]
28. Role of adipose-derived stem cells in wound healing. Hassan WU; Greiser U; Wang W Wound Repair Regen; 2014; 22(3):313-25. PubMed ID: 24844331 [TBL] [Abstract][Full Text] [Related]
29. Towards a gene therapy clinical trial for epidermolysis bullosa. Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M Rev Recent Clin Trials; 2006 May; 1(2):155-62. PubMed ID: 18473966 [TBL] [Abstract][Full Text] [Related]
31. Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa. Liao Y; Ivanova L; Zhu H; Yahr A; Ayello J; van de Ven C; Rashad A; Uitto J; Christiano AM; Cairo MS Stem Cells; 2015 Jun; 33(6):1807-17. PubMed ID: 25640200 [TBL] [Abstract][Full Text] [Related]
32. Potential mesenchymal stem cell therapy for skin diseases. Li X; Hamada T; Ohata C; Furumura M; Hashimoto T Exp Dermatol; 2013 Aug; 22(8):515-6. PubMed ID: 23879810 [TBL] [Abstract][Full Text] [Related]
33. Epidermal Stem Cells in Skin Wound Healing. Li Y; Zhang J; Yue J; Gou X; Wu X Adv Wound Care (New Rochelle); 2017 Sep; 6(9):297-307. PubMed ID: 28894637 [No Abstract] [Full Text] [Related]
34. Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa. Perdoni C; McGrath JA; Tolar J Stem Cell Res Ther; 2014 Nov; 5(6):121. PubMed ID: 25376815 [TBL] [Abstract][Full Text] [Related]
35. Stem cell therapy in dermatology. Khandpur S; Gupta S; Gunaabalaji DR Indian J Dermatol Venereol Leprol; 2021; 87(6):753-767. PubMed ID: 34245532 [TBL] [Abstract][Full Text] [Related]
36. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review. Bacakova L; Zarubova J; Travnickova M; Musilkova J; Pajorova J; Slepicka P; Kasalkova NS; Svorcik V; Kolska Z; Motarjemi H; Molitor M Biotechnol Adv; 2018; 36(4):1111-1126. PubMed ID: 29563048 [TBL] [Abstract][Full Text] [Related]
37. Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. Mizuno H J Nippon Med Sch; 2009 Apr; 76(2):56-66. PubMed ID: 19443990 [TBL] [Abstract][Full Text] [Related]
38. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors. Bhonde RR; Sheshadri P; Sharma S; Kumar A Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096 [TBL] [Abstract][Full Text] [Related]